Facebook

Make it Happen!

MSF’s campaign in support of a medicines patent pool calls on drug companies to put their HIV patents in the pool for all developing countries to deliver affordable, life-saving medicines.

12. July 2011
|
Gilead Licence Expands Access, But Several Countries Left Out

Gilead became the first company to license several HIV drugs to the Medicines Patent Pool which could help ensure that new treatment options are available in developing countries. But, disappointingly, it excludes key countries with large numbers of people living with HIV.

» Read more

Kenya 2011 © Sven Torfinn

About the Campaign

© MSF / lumierenoire.ch

MSF launched the ‘Make it Happen’ campaign in 2009, calling on nine pharmaceutical companies to put their HIV medicines patents in the patent pool being set up by UNITAID.

» Find out more

The Results

Austria 2010 © Marcell Nimfuehr / MSF

By December 2009, almost 300 000 letters were sent by supporters from 14 countries in nine languages to the nine companies being asked to put their patents in the pool.

Voices of the Campaign

© REUTERS / Finbarr O'Reilly

Patients on HIV treatment and doctors from MSF’s project in Khayelitsha, South Africa, explain why they are backing the creation of a patent pool.

» Watch now

Track the Pool's Progress

Track the progress of the Medicines Patent Pool by visiting their website or following them on Twitter, @MedsPatentPool.

You can directly access the status of negotiations with companies here

Next steps

20 July 2011 - The drive behind the Pool was to find a solution to the lack of access to newer HIV/AIDS medicines and to combination treatments for people living in developing countries. Now that the first company licence to the Pool has been announced, we are encouraging other companies to join the Pool, so that it can realise its potential- but we are calling on them to go further than Gilead in terms of not excluding any developing countries from licences. If countries are excluded then we would call on them issue compulsory licences to gain access to the needed medicines.

↑ To top